Sun Pharma, Cipla recall products in US over manufacturing issues

Drugmakers Sun Pharma and Cipla are recalling products in the US due to manufacturing-related issues, according to the US Food and Drug Administration (USFDA). The US-based arm of Mumbai-based Sun Pharma is recalling over 26,000 bottles of a generic medication used to treat dandruff and inflammatory skin conditions. Meanwhile, Cipla's US arm is recalling 15,221 syringes from the American market.